ACTRN12612000198820已完成2 期
21 day trial into the weight reduction effects of supplementation with 1g and 500mg SolaThin in adults aged between 18 and 40 with a Body Mass Index (BMI) of over 30.
CYVEX NUTRITION, INC0 个研究点目标入组 60 人开始时间: 2012年2月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •Participants who meet the following eligibility criteria will be recruited in the trial:
- •1.Males and females aged 18-40 with Body Mass Index (BMI) >30, otherwise healthy.
- •2.Are comfortable with computers and willing and able to participate in all scheduled visits, treatment plan, tests and other trial procedures according to the protocol.
- •3.Are comfortable with taking a daily supplement of SolaThin or Placebo for 21 days.
- •4.Provide a personally signed and dated informed consent indicating that the participant has been informed of all pertinent aspects of the trial.
排除标准
- •Participants presenting with any of the following will not be included in the trial:
- •1.History of anxiety, depression, psychiatric disorders.
- •2.History of / do not currently suffer from heart disease or high blood pressure or diabetes
- •3.Taking any medication, herbal extracts, vitamin supplements or illicit drugs for 4 weeks prior to (and duration of) study
- •4.Taking any form of medication within 5 days of admission (except for prophylactic antibiotics, or other routine medications to treat benign conditions, such as antibiotics to treat acne) and agree not to take any medication throughout the study
- •5.Health conditions that would affect food metabolism including the following: food allergies, kidney disease, liver disease and/or gastrointestinal diseases (e.g. Irritable bowel syndrome, coeliac disease, peptic ulcers)
- •6.Renal function problems, Hypercalcaemia; Hypermagnesemia, Severe hypercalciuria, phenylketonuria (autosomal metabolic disorder),
- •7.Currently pregnant or lactating
研究者
相似试验
已完成
不适用
Fatty acid metabolism and heart diseaseACTRN12605000107628Professor Ian Puddey40
已完成
不适用
A randomised trial assessing weight loss and quadriceps strengthening exercises as interventions for reducing knee pain in the community in overweight peopleKnee pain, obesityMusculoskeletal DiseasesKnee painISRCTN93206785Arthritis Research Campaign (ARC) (UK)389
已完成
不适用
Study to investigate weight loss using ?virtual gastric band? hypnotherapy compared to ?relaxation? hypnotherapy and following a self directed diet.Overweight and obesityNutritional, Metabolic, EndocrineObesityISRCTN69640604niversity of Hull (UK)30
尚未招募
不适用
Confirmation trial for the ameliorating effects of lactobacillus acidophilus strain L-92 on borderline symptoms of perennial allergic rhinitisHealthy AdultJPRN-UMIN000024464Sapporo Yurinokai Hospital160
进行中（未招募）
1 期
A research study to compare two types of insulin, a new weekly insulin, insulin icodec and an available daily insulin, insulin degludec, in people with type 2 diabetes who use daily insuliMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2020-000454-10-BGovo Nordisk A/S520